CAMP4 Therapeutics Corporation
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $179M
Investors
- 7
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation focuses on innovating RNA therapies to tackle genetic diseases. Founded in 2016 in Cambridge, US, by Leonard Zon and Richard Young, the company has undergone strategic pivots to enhance its research and product offerings.000 mn.CAMP4 specializes in innovative RNA treatments aimed at correcting gene expression to combat genetic disorders.In 2022, CAMP4 reported no revenue.82 million shares at USD 11 per share. The funds will support the launch of new RNA therapies and potential market expansion into Asia and South America by 2025. The IPO listing valued the company at approximately USD 280 mn and included a 30-day option for underwriters to purchase additional shares.
Who invested in CAMP4 Therapeutics Corporation
7 investors across 3 rounds
See all investors in CAMP4 Therapeutics Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CAMP4 Therapeutics Corporation
Who invested in CAMP4 Therapeutics Corporation?
CAMP4 Therapeutics Corporation has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CAMP4 Therapeutics Corporation raised?
CAMP4 Therapeutics Corporation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CAMP4 Therapeutics Corporation last raise money?
CAMP4 Therapeutics Corporation's most recent round on record is a Series B, in Jun 2022.
What does CAMP4 Therapeutics Corporation do?
CAMP4 Therapeutics Corporation focuses on innovating RNA therapies to tackle genetic diseases.
Where is CAMP4 Therapeutics Corporation headquartered?
CAMP4 Therapeutics Corporation is headquartered in Cambridge, US.
Which VCs invest in companies like CAMP4 Therapeutics Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CAMP4 Therapeutics Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CAMP4 Therapeutics Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.